CME Learning Center

Gynecologic Cancer

Intermingling Genomics and Ovarian Cancer Treatment Decisions CME / ABIM MOC Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?
Medscape Education Oncology, September 2023
Expert Perspectives on Health Equity and Disparities in Immunotherapy Cancer Care CME / ABIM MOC / CE Are you up to date on the disparities in immunotherapy cancer care and ways to achieve health equity?
Medscape Education Oncology, June 2023
Designing and Using Antibody-Drug Conjugates to Treat Solid Tumors CME / ABIM MOC How much do you know about antibody-drug conjugates (ADCs) for solid tumor management?
Medscape Education Oncology, April 2023
Enhancing the Value of Endometrial Cancer Care With Immunotherapy Regimens: A Managed Care Mindset CE Do you know how to enhance the care of your patients with endometrial cancer from a managed care perspective?
Medscape Education Pharmacists, April 2023
Ovarian Cancer Virtual Patient Case Simulation: How Do You Incorporate Maintenance Therapy? CME / ABIM MOC Integrating maintenance therapy into treatment for patients with ovarian cancer
Medscape Education Oncology, March 2023
Ovarian Cancer Consult: Adapting to PARP Inhibitors CME / ABIM MOC Three case studies illustrate the use of poly(ADP-ribose) polymerase (PARP) inhibitors in the management of ovarian cancer.
Medscape Education Ob/Gyn & Women's Health, January 2023
Endometrial Cancer Consult: Optimal Management Across the Disease Continuum CME / ABIM MOC Do you know the best management strategies and the latest clinical data for advanced endometrial cancer (EC)?
Medscape Education Oncology, January 2023
Understanding the Genomics of Ovarian Cancer: PARP Inhibitors Edition CME / ABIM MOC Do you understand why poly(ADP-ribose) polymerase (PARP) inhibitors are used to treat patients with advanced ovarian cancer?
Medscape Education Oncology, November 2022
Managing the Care of Ovarian Cancer With Poly(ADP-Ribose) Polymerase Inhibitors: A Managed Care Approach CME / ABIM MOC / CE
Medscape Education Pharmacists, November 2022
An Expert Perspective: Managing Advanced/Recurrent Endometrial Cancer CME / ABIM MOC Did you know that immunotherapy is now a second-line option for patients with advanced/recurrent endometrial cancer? Find out more here.
Medscape Education Oncology, November 2022
Antibody-Drug Conjugates 101: A Multidisciplinary Perspective of ADC Use in Solid Tumors CE Thinking about using antibody-drug conjugates (ADCs) in patients with solid tumors? Join this discussion with our experts for strategies and perspectives.
Medscape Education Oncology, October 2022
A Clinical Case Symposium: PARP Inhibitors in Advanced Ovarian Cancer and the Impact on Survival CME / ABIM MOC How should poly(ADP-ribose) polymerase (PARP) inhibitors be used in the wake of new data in advanced ovarian cancer (OC)?
Medscape Education Oncology, October 2022
The Nurse View: Incorporating PARP Inhibitor Therapy in Advanced Ovarian Cancer Management  CE Are you aware of the recent changes to the approved indications for poly (ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer?
Medscape Education Nurses, September 2022
Paris Pearls: Targeting Antibody-Drug Conjugates in Solid Tumors CME / ABIM MOC Exciting results in direct-aiming antibody-drug conjugates (ADCs) have recently been released for breast, ovarian, and lung cancer. Are you up to date?
Medscape Education Oncology, September 2022
Pathology State of Affairs: Underscoring the Value of Biomarker Testing for Solid Tumors  CME / ABIM MOC Are you up to date with current best practices for biomarker testing in solid malignancies? Find out more here!
Medscape Education Pathology, September 2022
Gynecologic Malignancies: Status Updates From the 2022 Annual Oncology Meeting in Chicago Are you up to date with the latest in gynecologic cancer clinical research?
Medscape Education Oncology, July 2022
Raising the Bar in HPV Screening - Power of Informed Prevention and Triage in Clinical Practice CME / ABIM MOC Did you know some cervical cancer screening guidelines advise against screening patients younger than 25 years?
Medscape Education Ob/Gyn & Women's Health, June 2022
The Afternoon Show in Gynecologic Oncology: Interactive Perspectives in Advanced Endometrial Cancer CME / ABIM MOC Dr Slomovitz presents key points that were presented at a recent live meeting at SGO focused on endometrial cancer.
Medscape Education Oncology, April 2022
The Afternoon Show in Gynecologic Oncology: PARP Inhibitors Across the Ovarian Cancer Disease Continuum CME / ABIM MOC Do you know which of your ovarian cancer patients is eligible to receive PARP inhibitors? Find out more from Dr Oaknin!
Medscape Education Oncology, April 2022
Obstacles and Opportunities: How Do We Increase Adult Immunization Rates? CME / ABIM MOC / CE Our experts brainstorm about strategies for overcoming challenges/barriers to increasing vaccination rates among adults.
Medscape Education Family Medicine, April 2022

Does Metabolic Health Affect Cancer Risk? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 23, 2023
Medscape Now! Hot Topics in Family Medicine June 2023 Part 1 CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 15, 2023
Can Low-Cost Interventions Improve Cancer Screenings for Women in Remote Areas? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 2, 2023
Are Mothers With Disabilities Less Likely to Initiate Breastfeeding? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, February 17, 2023
Does Age Matter? Human Papillomavirus Vaccine Effectiveness CME / ABIM MOC / CE
Medscape Education Clinical Briefs, December 23, 2022

CME Learning Center

Gynecologic Cancer

Latest Clinical Briefs

Further Reading